H19 and amyotrophic lateral sclerosis: In light of these findings, H19 may also represent a compelling target for ALS treatment, based on the hypothesis that elevated levels of this lncRNA may contribute to muscle atrophy and skeletal muscle fibrosis, as previously discussed.